Remove 2020 Remove Data Remove Patients Remove Treatment
article thumbnail

Published data on cannabis treatment to reduce opioid usage

Healer

The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronic pain patients. Healer conducted an online convenience sample survey of patients from three medical cannabis practice sites who had reported using opioids. Peer Reviewed Medical Study . Read full published study.

article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

article thumbnail

CDC Still Soliciting Comments Regarding Chronic Pain Management Solutions

NORML

The deadline to submit comments to the agency is Tuesday, June 16, 2020. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments. percent in 2016).” percent in 2016).”

article thumbnail

Survey Reveals Almost Half of Canada’s MMJ Patients Reduced Their Alcohol and Opioid Consumption

Veriheal

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 Furthermore, 25.4%

article thumbnail

CannaMD Partners with Releaf App: Tracking Patient Outcomes

CannaMD

Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. Patients can learn more by visiting ReleafApp.com.

article thumbnail

Marijuana & COVID-19: Top Studies [August 2020]

CannaMD

While COVID-19 can be deadly, the World Health Organization (WHO) stresses that most patients experience mild cases and/or survive: Most people who get COVID-19 have mild or moderate symptoms and can recover thanks to supportive care. ” And their alternative strategy of choice? Terpenes and CBD: Twice as Effective.